NHS National Framework Agreement for Macitentan & Cladribine Tablets

Project title: NHS National Framework Agreement for Macitentan & Cladribine Tablets

Offer reference number: CM/TNS/26/5748

Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.

CM/TNS/26/5748/01 Macitentan

Lot 1 DCE/DLN: 01/10/2027 to 30/09/2029 (24 months) CELN

Lot 2 DNW/DLS: 01/10/2027 to 31/01/2029 (16 months) NWLS

Lot 3 DNE/DSW: 01/10/2027 to 30/09/2029 (24 months) NESW

CM/TNS/26/5748/02 Cladribine Tablets

Lot 1 DCE/DSW: 01/10/2027 to 30/09/2029 (24 months) CESW

Lot 2 DLN/DNW: 01/10/2027 to 31/01/2029 (16 months) NWLN

Lot 3 DLS/DNE: 01/10/2027 to 30/09/2028 (12 months) LSNE

Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England